Back
Janux Therapeutics Stock Price Chart
Sponsored
JANX
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
JANX
Janux Therapeutics
Last Price:
$56.16
Seasonality Move:
84.76%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and JANX is experiencing slight selling pressure.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.48 | Sell |
20-day SMA: | 56.84 | Sell |
50-day SMA: | 53.9 | Buy |
200-day SMA: | 46.87 | Buy |
8-day EMA: | 58.36 | Sell |
20-day EMA: | 57.34 | Sell |
50-day EMA: | 54.07 | Buy |
200-day EMA: | 44.13 | Buy |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.74 | Buy |
Relative Strength Index (14 RSI): | 50.46 | Buy |
Chaikin Money Flow: | -590713 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.53 - 62.71) | Buy |
Bollinger Bands (100): | (41.93 - 55.93) | Buy |
Janux Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 56.71 while JANX 8-day simple moving average is 59.48, which is a Sell signal.
-
The stock price of JANX is 56.71 while Janux Therapeutics 20-day SMA is 56.84, which makes it a Sell.
-
Janux Therapeutics 50-day simple moving average is 53.90 while JANX share price is 56.71, making it a Buy technically.
-
JANX stock price is 56.71 and Janux Therapeutics 200-day simple moving average is 46.87, creating a Buy signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
28
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a SellThe current Janux Therapeutics [JANX] share price is $56.71. The Score for JANX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
3B
Price in USD:
56.71
Share Volume:
1.3M
Janux Therapeutics 52-Week Range
52-Week High:
71.71
52-Week Low:
7.79
Sell
28
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?The Janux Therapeutics stock price is 56.71 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 56.71 while JANX 8-day exponential moving average is 58.36, which is a Sell signal.
-
The stock price of JANX is 56.71 while Janux Therapeutics 20-day EMA is 57.34, which makes it a Sell.
-
Janux Therapeutics 50-day exponential moving average is 54.07 while JANX share price is 56.71, making it a Buy technically.
-
JANX stock price is 56.71 and Janux Therapeutics 200-day simple moving average is 44.13, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.97 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is 1.74, suggesting Janux Therapeutics is a Buy
-
Janux Therapeutics Relative Strength Index (RSI) is 50.46, which suggest Janux Therapeutics is overbought
-
The Bollinger Bands (25) for Janux Therapeutics is (47.53 - 62.71), which suggest Janux Therapeutics is a Buy
-
The Bollinger Bands (100) for Janux Therapeutics is (41.93 - 55.93), which suggest Janux Therapeutics is a Buy
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.